查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1999285

神经科病患监测市场：按产品类型、监护模式、组件、连接方式、技术、部署方法、应用和最终用户划分－2026-2032年全球市场预测

Neurology Patient Monitoring Market by Product Type, Monitoring Mode, Component, Connectivity, Technology, Deployment Mode, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年神经病学领域的病患监测市场价值为 60 亿美元，预计到 2026 年将成长至 65 亿美元，复合年增长率为 9.70%，到 2032 年将达到 114.9 亿美元。

主要市场统计数据
基准年 2025 60亿美元
预计年份：2026年 65亿美元
预测年份 2032 114.9亿美元
复合年增长率 (%) 9.70%

对神经科病患监测领域进行全面概述，揭示临床因素、技术融合以及相关人员的关键决策因素。

在临床需求、技术创新和医疗服务模式转移的交会下，神经病学病患监测领域正迅速发展。本文阐述了推动投资和应用的关键临床需求，包括持续、准确的神经系统数据对于改善急慢性疾病治疗效果的重要性，并解释了这一领域的发展背景。此外，本文还说明了感测技术、讯号处理和软体分析的整合如何重新定义即时监护对临床医生和看护者的价值。

感测技术、人工智慧驱动的分析以及混合护理模式的快速发展如何重塑神经监测领域的临床工作流程、监管预期和竞争优势。

神经病学领域的病患监测市场正经历着变革性的转变，这些变革正在加速临床应用，并重塑市场竞争动态。感测器精度和讯号采集技术的进步带来了前所未有的洞察。同时，边缘处理和云端分析技术能够加快资料解读速度，并发出可操作的警报。此外，人工智慧在数据解读过程中的应用，透过检测异常情况、确定病例优先顺序和缩短干预时间，显着提升了临床医生的工作流程。因此，价值的焦点正从原始资料收集转向智慧化的、情境化的决策支援。

本研究探讨了 2025 年关税政策的变化将如何促使供应链重组、采购多元化以及策略采购政策的转变，进而影响神经监测操作。

美国2025年实施的关税可能会引发神经系统疾病病患监测生态系统内一系列运作和策略调整。进口零件和成品的成本波动将影响筹资策略，促使供应商重新评估其供应链布局，并探索近岸外包和替代采购方案。随着各机构的调整，采购週期和供应商谈判可能会延长，从而影响医疗机构设备的可用性和部署速度。

多层分割分析，阐明产品模式、监测模式、临床应用、最终用户环境、组件、部署选项、连接方式以及推动部署的技术方向。

精准的市场区隔观点揭示了创新和应用集中的领域，以及仍存在未满足需求的领域。就产品类型而言，脑电图 (EEG)、肌电图 (EMG)、颅内压监测系统和经颅都卜勒设备各自拥有独特的临床应用场景、检验流程和整合要求，供应商需要根据急性神经重症监护和长期门诊评估的不同需求来调整其价值提案。从监测模式的角度来看，诸如皮层脑电图和颅内压监测等侵入性解决方案可为重症监护中的决策提供高度精确的讯号。另一方面，包括脑电图、肌电图和经颅都卜勒在内的无创技术适用于包括门诊、睡眠和神经科科诊所在内的多种环境，从而形成了互补的应用曲线，并对临床医生培训和监管核准提出了不同的要求。

医疗保健系统、法规结构和数数位化准备的区域差异如何影响世界各地的优先事项、商业化和在地化策略？

区域趋势正在形成差异化的需求讯号和法规环境，进而影响产品策略、伙伴关係和商业化计画。在美洲，临床应用通常与综合医疗保健系统和大学医院密切相关，这些机构优先考虑用于重症监护和研究的先进监测技术；与此同时，在以价值为基础的医疗和远端病患管理措施的推动下，人们对家庭监测的兴趣也迅速增长。在欧洲、中东和非洲，报销体系和医疗基础设施的差异造成了临床需求和成本控制要求必须兼顾的复杂局面，因此，制定个人化的证据建构和分发策略对于应对当地的监管流程至关重要。

深入了解产品历史、软体差异化、策略伙伴关係和售后支援如何决定神经监测领域的竞争优势和采用轨迹。

神经系统疾病病患监测领域的竞争动态是由传统医疗设备专业知识、新兴软体能力以及连接临床、技术和服务能力的策略联盟共同塑造的。成熟的医疗设备製造商拥有丰富的临床检验经验和分销网络，能够促进医院层面的部署；而新参与企业和科技公司则透过软体主导的产品、人工智慧和以用户为中心的设计脱颖而出。医疗设备製造商、临床研究机构和云端平台供应商之间的伙伴关係能够快速产生证据并实现可扩展的部署，从而创造出一种合作模式优于纯粹内部成长策略的环境。

为领导者提供实用指导，以协调产品模组化、临床检验、部署柔软性和强大的采购系统，从而确保长期部署和营运弹性。

产业领导者应采取协调一致的策略，将产品开发、法规遵循规划和商业性执行有机结合，以确保临床相关性和营运永续性。优先考虑模组化产品架构，实现组件重复使用和快速迭代，从而降低供应链中断和关税相关成本压力。同时，投资强大的资料管治、网路安全和临床检验项目，以支援人工智慧驱动的功能，并确保可解释性和临床医生的信任。这些投资有助于跨司法管辖区的解决方案认证，并满足医院的IT和合规要求。

我们以证据为基础的调查方法，结合了直接的临床相关人员、间接的技术审查和结构化的分析方法，为决策者提供了可操作的见解。

本研究整合了对临床医生、医疗系统采购经理和产品主管的定性研究，并辅以对监管申报文件、临床文献和公开技术文件的二次分析，旨在全面了解神经病学领域的病患监测技术及其应用趋势。研究整合了主要资讯来源，以提取有关工作流程整合、临床优先事项和采购决策标准的经验性见解；同时，研究也整合了二级资讯来源，以提供技术背景，并对设备功能和监管考虑进行三角检验。

我们透过简洁地整合策略挑战，将创新转化为临床影响，这些策略挑战优先考虑互通性、证据生成、稳健实施和以临床医生为中心的设计。

总之，神经病学领域的病患监测正处于转折点，其驱动力包括技术的成熟、医疗服务模式的演进以及供应链趋势的转变。能够整合高精度感测、可解释分析和灵活部署方案的机构，将更有能力满足医院、门诊中心和居家照护机构的多样化需求。同样重要的是，这些机构还需具备克服监管复杂性、透过真实世界数据展现临床价值以及在政策和经济逆风中保持稳健的供应链和生产策略的能力。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：神经病学病患监测市场：依产品类型划分

  • 脑电图（EEG）
  • 肌电图（EMG）
  • ICP监测系统
  • TCD设备

第九章：神经病学领域的病患监测市场－依监护方法划分

  • 侵入性
    • 脑电皮层图
    • ICP监测
  • 非侵入性
    • 脑电图（EEG）
    • EMG
    • TCD

第十章：神经病学病患监测市场：依组件划分

  • 硬体
  • 服务
  • 软体

第十一章 神经病学病患监测市场：连结性

  • 有线
  • 无线的

第十二章 神经病学病患监测市场：依技术划分

  • 人工智慧
  • 传统的

第十三章：神经病学病患监测市场：依部署模式划分

  • 基于云端的
  • 现场

第十四章 神经病学病患监测市场：依应用领域划分

  • 癫痫监测
  • 神经退化性疾病监测
  • 睡眠障碍监测
  • 中风监测

第十五章：神经病学病患监测市场：依最终用户划分

  • 门诊部
  • 居家照护设施
  • 医院

第十六章 神经科病患监测市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十七章 神经病学病患监测市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十八章 神经病学病患监测市场：按国家/地区划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十九章：美国神经病学领域的病患监测市场

第二十章：中国神经病学领域的病患监测市场

第21章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Advanced Brain Monitoring, Inc.
  • BioSerenity SAS
  • BrainScope Company, Inc.
  • Cadwell Industries, Inc.
  • Compumedics Limited
  • Dragerwerk AG & Co. KGaA
  • Electrical Geodesics, Inc.（EGI）
  • Gaeltec Devices Limited
  • GE HealthCare
  • Integra LifeSciences Holdings Corporation
  • Koninklijke Philips NV
  • Masimo Corporation
  • Medtronic plc
  • Natus Medical Incorporated
  • Neural Analytics, Inc.
  • NeuroSky, Inc.
  • Neurosoft Ltd.
  • NeuroWave Systems, Inc.
  • Nihon Kohden Corporation
  • Nonin Medical, Inc.
  • Raumedic AG
  • Rimed Ltd.
  • Siemens Healthcare GmbH
  • Sophysa SAS
  • Spiegelberg GmbH & Co. KG
Product Code: MRR-3A2E844FCDB5

The Neurology Patient Monitoring Market was valued at USD 6.00 billion in 2025 and is projected to grow to USD 6.50 billion in 2026, with a CAGR of 9.70%, reaching USD 11.49 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.00 billion
Estimated Year [2026] USD 6.50 billion
Forecast Year [2032] USD 11.49 billion
CAGR (%) 9.70%

A comprehensive orientation to the neurology patient monitoring landscape that clarifies clinical drivers, technological convergence, and critical decision levers for stakeholders

The neurology patient monitoring domain is undergoing rapid evolution as clinical demand intersects with technological innovation and shifting care delivery paradigms. This introduction sets the stage by clarifying the clinical imperatives driving investment and adoption, including the need for continuous, accurate neurological data to improve outcomes across acute and chronic conditions. It also outlines how convergence among sensing technologies, signal processing, and software-enabled analytics is redefining what real-time monitoring can deliver for clinicians and caregivers.

Against this backdrop, stakeholders must understand the interplay of device modalities, monitoring modes, and care environments that shape procurement and deployment decisions. The landscape is influenced by hospital infrastructure, the maturation of home and ambulatory care models, regulatory scrutiny of data integrity and cybersecurity, and growing expectations for interoperability. By framing these forces early, readers gain a practical foundation for evaluating technologies, partnerships, and capabilities that will determine competitive differentiation and clinical value in the coming years.

How rapid advances in sensing, AI-driven analytics, and hybrid care models are reshaping clinical workflows, regulatory expectations, and competitive moats in neurology monitoring

The neurology patient monitoring space is experiencing transformative shifts that are accelerating clinical adoption and redefining competitive dynamics. Advancements in sensor fidelity and signal acquisition are enabling previously unobtainable insights, while edge processing and cloud-enabled analytics allow for faster interpretation and actionable alerts. Simultaneously, the integration of artificial intelligence into interpretation pipelines is augmenting clinician workflows by flagging anomalies, prioritizing cases, and reducing time to intervention, thus shifting the locus of value from raw data capture to intelligent, context-aware decision support.

In addition to technological progress, care-delivery models are shifting away from exclusive reliance on inpatient monitoring toward hybridized approaches that blend ambulatory, home-based, and hospital settings. This transition requires more robust connectivity architectures, flexible deployment options, and an emphasis on patient-centric device ergonomics. Regulatory frameworks are also evolving to address software as a medical device, data privacy, and post-market surveillance, which in turn influences product design, validation strategies, and commercialization pathways. Consequently, organizations that align product innovation with clinical workflows, regulatory foresight, and scalable support models will capture greater clinical relevance and operational traction as these transformative forces converge.

Examining how tariff policy changes in 2025 can prompt supply chain reconfiguration, sourcing diversification, and strategic procurement shifts affecting neurology monitoring operations

The introduction of United States tariffs in 2025 has potential to create a cascade of operational and strategic adjustments across the neurology patient monitoring ecosystem. Tariff-driven cost changes for imported components and finished devices can influence procurement strategies, prompting suppliers to reassess supply chain footprints and to explore near-shoring or alternative sourcing. As organizations adapt, procurement timelines and vendor negotiations may extend, which could affect device availability and the pacing of deployments in clinical settings.

Beyond immediate cost implications, tariffs can catalyze broader supplier rationalization and design-for-manufacturability efforts that emphasize component standardization and modular architectures. These responses may spur greater collaboration between device manufacturers and contract manufacturers to localize production or redesign products to reduce tariff exposure. At the same time, providers and health systems might prioritize vendors with resilient supply chains and clear mitigation plans, thereby reshaping vendor selection criteria. Over the medium term, the cumulative effects of tariff policy will be mediated by corporate responses, currency movements, and the evolving balance between cost pressures and the clinical imperative to maintain uninterrupted neurologic monitoring capabilities.

A layered segmentation analysis that deciphers product modalities, monitoring modes, clinical applications, end-use environments, components, deployment options, connectivity, and technology vectors driving adoption

A nuanced segmentation lens illuminates where innovation and adoption are concentrated and where unmet needs persist. When considering product categories, electroencephalography (EEG), electromyography (EMG), intracranial pressure monitoring systems, and transcranial Doppler devices each carry distinct clinical use cases, validation pathways, and integration requirements, and vendors must tailor value propositions to the differential needs of acute neuro-critical care versus longitudinal ambulatory assessment. In terms of monitoring mode, invasive solutions such as electrocorticography and intracranial pressure monitoring offer high-fidelity signals for critical care decision making, while non invasive techniques including EEG, EMG, and transcranial Doppler provide broader applicability across outpatient, sleep, and neurology clinic contexts, creating complementary adoption curves and differing requirements for clinician training and regulatory clearance.

Application-focused segmentation further refines opportunity areas, with epilepsy monitoring demanding high temporal resolution and artifact rejection; neurodegenerative disease monitoring emphasizing longitudinal data capture and patient comfort; sleep disorder monitoring requiring home-friendly, minimally obtrusive designs; and stroke monitoring prioritizing rapid detection and integration with acute care pathways. End-user distinctions reveal distinct procurement cycles and support needs across ambulatory care centers, home care settings, and hospitals, each of which imposes specific constraints related to staffing, infrastructure, and reimbursement. Component segmentation separates hardware, services, and software revenue streams and underscores the rising importance of software-driven analytics and post-sale clinical support. Deployment mode differences between cloud-based and on-premise solutions shape data governance, latency, and scale considerations, while connectivity choices between wired and wireless determine installation complexity, mobility, and patient experience. Finally, technology differentiation between AI-enabled systems and traditional approaches highlights divergent development priorities: AI-enabled offerings require robust training datasets, explainability, and post-market performance monitoring, whereas traditional systems focus on deterministic algorithms and certified signal processing pipelines. Taken together, these segmentation perspectives enable a layered understanding of where clinical value is realized, how adoption barriers vary, and where strategic investments will yield the greatest returns.

How geographic differences in healthcare systems, regulatory frameworks, and digital readiness shape prioritization, commercialization, and localization strategies across global regions

Regional dynamics create differentiated demand signals and regulatory contexts that influence product strategy, partnerships, and commercialization plans. In the Americas, clinical adoption often aligns with integrated health systems and academic medical centers that prioritize advanced monitoring for critical care and research, alongside a rapidly growing interest in home-based monitoring driven by value-based care and remote patient management initiatives. Across Europe, Middle East & Africa, variations in reimbursement frameworks and healthcare infrastructure result in a heterogeneous landscape where clinical needs are balanced against cost containment imperatives, and where local regulatory pathways necessitate tailored evidence generation and distribution strategies.

In the Asia-Pacific region, accelerating investment in healthcare infrastructure, a strong emphasis on domestic manufacturing capability, and rapidly expanding patient populations are creating vigorous demand for scalable, cost-effective monitoring solutions. Each of these regional contexts also differs in digital health readiness, cybersecurity expectations, and clinical workforce capacity, which collectively shape product localization requirements, channel strategies, and service models. Therefore, firms seeking to expand their footprint must align regulatory planning, clinical evidence generation, and operational support with the distinct priorities and constraints present within each geographic region.

Insights into how product heritage, software differentiation, strategic partnerships, and post-sale support determine competitive advantage and adoption trajectories in neurology monitoring

Competitive dynamics in the neurology patient monitoring space are being defined by a combination of legacy device expertise, emergent software capabilities, and strategic alliances that bridge clinical, technological, and services competencies. Established device manufacturers contribute deep clinical validation experience and distribution networks that facilitate hospital-level adoption, while newer entrants and technology firms are differentiating through software-defined offerings, artificial intelligence, and user-centric design. Partnerships between device makers, clinical research entities, and cloud-platform providers are enabling accelerated evidence generation and deployment scalability, creating an environment where collaborative models often outpace purely organic growth strategies.

Moreover, companies that demonstrate clear post-sale clinical support, training programs, and evidence of real-world performance are gaining preferential access to procurement decision makers. Investment in regulatory affairs, quality systems, and cybersecurity governance further distinguishes credible suppliers from less mature players. As a result, competitive advantage accrues to organizations that can effectively combine validated sensing hardware, robust signal processing, and transparent, clinically validated analytics delivered through scalable service frameworks. This multi-dimensional approach to product and market execution is increasingly essential for achieving sustained traction in complex healthcare environments.

Action-oriented guidance for leaders to align product modularity, clinical validation, deployment flexibility, and resilient sourcing to secure long-term adoption and operational resilience

Industry leaders should pursue a coordinated strategy that aligns product development, regulatory planning, and commercial execution to capture clinical relevance and operational sustainability. Prioritize modular product architectures that enable component reuse and rapid iteration, thereby reducing exposure to supply chain disruptions and tariff-driven cost pressures. Simultaneously, invest in robust data governance, cybersecurity, and clinical validation programs that support AI-enabled functionality while ensuring explainability and clinician trust. These investments will make it easier to certify solutions across jurisdictions and to satisfy hospital IT and compliance requirements.

In the commercial realm, cultivate flexible deployment and pricing models that accommodate hospital, ambulatory, and home-based settings; emphasize bundled offerings that integrate hardware, software, and services to simplify procurement and to demonstrate downstream care benefits. Forge strategic clinical partnerships to build longitudinal evidence and to accelerate guideline adoption, and prioritize channels and support infrastructures that can rapidly scale training and technical assistance. Finally, maintain a proactive supply chain and sourcing strategy that includes diversified suppliers, regional manufacturing options where feasible, and design-for-manufacture principles to preserve margin and ensure continuity of care delivery as market conditions evolve.

An evidence-driven methodology combining primary clinical engagement, secondary technical review, and structured analytical approaches to produce actionable intelligence for decision makers

This research integrates primary qualitative engagements with clinicians, health system procurement leaders, and product executives, supplemented by secondary analysis of regulatory filings, clinical literature, and publicly available technical documentation to construct a holistic view of neurology patient monitoring technologies and adoption dynamics. Primary inputs were synthesized to capture experiential insights on workflow integration, clinical priorities, and procurement decision criteria, while secondary sources provided technical context and supported triangulation of device capabilities and regulatory considerations.

Analytical methods included comparative technology assessment, scenario analysis to evaluate the implications of policy and supply chain events, and segmentation mapping to identify unmet needs across product types, monitoring modes, applications, end users, components, deployment models, connectivity options, and technology approaches. Throughout the analysis, emphasis was placed on validation against clinician experience and on the transparency of assumptions related to adoption drivers, regulatory milestones, and operational constraints. The methodology therefore blends practitioner-informed perspectives with structured analytical techniques to provide actionable intelligence for decision makers.

A succinct synthesis of strategic imperatives emphasizing interoperability, evidence generation, resilient operations, and clinician-centered design to translate innovation into clinical impact

In conclusion, the neurology patient monitoring landscape is at an inflection point driven by technological maturation, evolving care delivery models, and shifting supply chain dynamics. Organizations that integrate high-fidelity sensing, explainable analytics, and flexible deployment options will be best positioned to meet the diverse needs of hospitals, ambulatory centers, and home care environments. Equally important is the ability to navigate regulatory complexity, to demonstrate clinical value through real-world evidence, and to maintain resilient supply and manufacturing strategies in the face of policy and economic headwinds.

As stakeholders plan next steps, they should focus on interoperability, clinician-centric design, and post-market performance monitoring to ensure sustained clinical adoption and patient benefit. By aligning product development, evidence generation, and commercial execution, leaders can convert technological promise into measurable clinical impact and durable organizational advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurology Patient Monitoring Market, by Product Type

  • 8.1. EEG
  • 8.2. EMG
  • 8.3. ICP Monitoring System
  • 8.4. TCD Device

9. Neurology Patient Monitoring Market, by Monitoring Mode

  • 9.1. Invasive
    • 9.1.1. Electrocorticography
    • 9.1.2. ICP Monitoring
  • 9.2. Non Invasive
    • 9.2.1. EEG
    • 9.2.2. EMG
    • 9.2.3. TCD

10. Neurology Patient Monitoring Market, by Component

  • 10.1. Hardware
  • 10.2. Services
  • 10.3. Software

11. Neurology Patient Monitoring Market, by Connectivity

  • 11.1. Wired
  • 11.2. Wireless

12. Neurology Patient Monitoring Market, by Technology

  • 12.1. AI Enabled
  • 12.2. Traditional

13. Neurology Patient Monitoring Market, by Deployment Mode

  • 13.1. Cloud Based
  • 13.2. On Premise

14. Neurology Patient Monitoring Market, by Application

  • 14.1. Epilepsy Monitoring
  • 14.2. Neurodegenerative Disease Monitoring
  • 14.3. Sleep Disorder Monitoring
  • 14.4. Stroke Monitoring

15. Neurology Patient Monitoring Market, by End User

  • 15.1. Ambulatory Care Centers
  • 15.2. Home Care Settings
  • 15.3. Hospitals

16. Neurology Patient Monitoring Market, by Region

  • 16.1. Americas
    • 16.1.1. North America
    • 16.1.2. Latin America
  • 16.2. Europe, Middle East & Africa
    • 16.2.1. Europe
    • 16.2.2. Middle East
    • 16.2.3. Africa
  • 16.3. Asia-Pacific

17. Neurology Patient Monitoring Market, by Group

  • 17.1. ASEAN
  • 17.2. GCC
  • 17.3. European Union
  • 17.4. BRICS
  • 17.5. G7
  • 17.6. NATO

18. Neurology Patient Monitoring Market, by Country

  • 18.1. United States
  • 18.2. Canada
  • 18.3. Mexico
  • 18.4. Brazil
  • 18.5. United Kingdom
  • 18.6. Germany
  • 18.7. France
  • 18.8. Russia
  • 18.9. Italy
  • 18.10. Spain
  • 18.11. China
  • 18.12. India
  • 18.13. Japan
  • 18.14. Australia
  • 18.15. South Korea

19. United States Neurology Patient Monitoring Market

20. China Neurology Patient Monitoring Market

21. Competitive Landscape

  • 21.1. Market Concentration Analysis, 2025
    • 21.1.1. Concentration Ratio (CR)
    • 21.1.2. Herfindahl Hirschman Index (HHI)
  • 21.2. Recent Developments & Impact Analysis, 2025
  • 21.3. Product Portfolio Analysis, 2025
  • 21.4. Benchmarking Analysis, 2025
  • 21.5. Advanced Brain Monitoring, Inc.
  • 21.6. BioSerenity SAS
  • 21.7. BrainScope Company, Inc.
  • 21.8. Cadwell Industries, Inc.
  • 21.9. Compumedics Limited
  • 21.10. Dragerwerk AG & Co. KGaA
  • 21.11. Electrical Geodesics, Inc. (EGI)
  • 21.12. Gaeltec Devices Limited
  • 21.13. GE HealthCare
  • 21.14. Integra LifeSciences Holdings Corporation
  • 21.15. Koninklijke Philips N.V.
  • 21.16. Masimo Corporation
  • 21.17. Medtronic plc
  • 21.18. Natus Medical Incorporated
  • 21.19. Neural Analytics, Inc.
  • 21.20. NeuroSky, Inc.
  • 21.21. Neurosoft Ltd.
  • 21.22. NeuroWave Systems, Inc.
  • 21.23. Nihon Kohden Corporation
  • 21.24. Nonin Medical, Inc.
  • 21.25. Raumedic AG
  • 21.26. Rimed Ltd.
  • 21.27. Siemens Healthcare GmbH
  • 21.28. Sophysa S.A.S.
  • 21.29. Spiegelberg GmbH & Co. KG

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEUROLOGY PATIENT MONITORING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 15. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 16. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 197. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 198. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 200. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 201. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 230. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 231. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 233. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 234. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 236. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 241. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 242. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 244. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 245. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 246. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)